Clinical Trial Update: Trial for Hepatocellular Carcinoma Adjuvant Treatment by Lipiocis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating Lipiocis as adjuvant treatment for hepatocellular carcinoma has completed; sponsor information includes ANRS and Emerging Infectious …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Viral Hepatitis

Drugs mentioned

• Lipiocis

Snippet

Sponsor: ANRS, Emerging Infectious Diseases | Conditions: Carcinoma, Hepatocellular, Hepatitis, Viral, Human | Phase 3 | Status: COMPLETED